Hovione Technology's 8Shot dry powder inhaler has been selected as a finalist for the 2021 Medical Design Excellence Awards (MDEA) in the Drug-Delivery and Combination Products category, the company said. The 8Shot DPI, which is designed for delivery of doses up to 400 mg, previously won a Red Dot 2020 Product Design Award in the Healthcare Daily Living Aids category. … [Read more...] about Hovione Technology’s 8Shot DPI selected as finalist for the 2021 MDEA competition
Products and Services
Kindeva and Cambridge Healthcare Innovations partner on development of CHI’s Aeolus DPI
Kindeva Drug Delivery has partnered with Cambridge Healthcare Innovations (CHI) for development and commercialization of CHI’s Aeolus DPI platform, the company said. The Aeolus device is breath-activated, blister-based, and comes in single use, reusable, and multi-unit dose versions. As part of the collaboration, Kindeva will supply product development and regulatory … [Read more...] about Kindeva and Cambridge Healthcare Innovations partner on development of CHI’s Aeolus DPI
Seelos says it has signed an agreement to use Aptar Pharma’s BDS device for its intranasal ketamine
Seelos Therapeutics has signed a strategic device partnership agreement with Aptar Pharma for the use of Aptar's Bidose Liquid System (BDS) for Seelos' SLS-002 intranasal ketamine, Seelos said. SLS-002 is in Phase 2 development for the treatment of suicidal ideation in patients with major depressive disorder. The company noted that the agreement also includes the … [Read more...] about Seelos says it has signed an agreement to use Aptar Pharma’s BDS device for its intranasal ketamine
Iconovo to develop inhaled COVID-19 vaccine delivered by the ICOone device for ISR
According to Iconovo, Swedish immunotherapy developer Immune System Regulation (ISR) will pay up to 18.1 million Swedish kronor plus potential royalties for development of a dry powder COVID-19 vaccine delivered via Iconovo’s ICOone single dose DPI. The deal also includes an option for ISR to use the ICOone device for delivery of vaccines for other respiratory … [Read more...] about Iconovo to develop inhaled COVID-19 vaccine delivered by the ICOone device for ISR
Coster and Lindal announce the launch of joint venture RxPack to market inhalation and nasal devices, filling equipment
Coster and Lindal have announced that they will each transfer their pharmaceutical aerosol businesses into a new company called RxPack, which will operate independently of both parent companies. RxPack will distribute Coster's aerosol filling equipment in addition to manufacturing MDIs, nasal spray pumps, and other OINDP devices; Coster and Lindal will continue to … [Read more...] about Coster and Lindal announce the launch of joint venture RxPack to market inhalation and nasal devices, filling equipment
Summit Biosciences to produce multidose nasal spray version of Altimmune’s AdCOVID vaccine
Altimmune announced that it has signed a manufacturing agreement with Summit Biosciences for a multidose version of Altimmune's AdCOVID intranasal vaccine against COVID-19. The announcement comes shortly after Altimmune announced an agreement with Lonza for manufacturing of the single dose version of the vaccine in a dedicated suite at Lonza's Texas facility. A Phase … [Read more...] about Summit Biosciences to produce multidose nasal spray version of Altimmune’s AdCOVID vaccine
Copley launches Inhalytix cascade impactor software
Copley Scientific has launched a new software package for cascade impactor management and data analysis called "Inhalytix," which succeeds the company's long-established CITDAS cascade impactor software. The new software, which is 21 CFR Part 11 compliant, can be used with a variety of cascade impactors, including the NGI, the Andersen impactor, and the Fast Screening … [Read more...] about Copley launches Inhalytix cascade impactor software
Lonza to dedicate manufacturing suite to Altimmune’s AdCOVID intranasal vaccine
In an expansion of a manufacturing agreement between Altimmune and Lonza that was announced in November 2020, Lonza has agreed to dedicate a manufacturing suite at its Texas facility for production of Altimmune's AdCOVID intranasal vaccine. The FDA cleared Altimmune's IND for a Phase 1 trial of AdCOVID in February 2021. According to Altimmune, AdCOVID a single dose … [Read more...] about Lonza to dedicate manufacturing suite to Altimmune’s AdCOVID intranasal vaccine
Copley Scientific introduces new products for nasal spray testing
Copley Scientific, which recently made multiple updates to its range of OINDP testing equipment, has announced the launch of a new range of accessories for testing nasal sprays, including metered dose and dry powder nasal products. The new Copley products include accessories for delivered dose uniformity (DDU) testing of nasal products as well as for improved in … [Read more...] about Copley Scientific introduces new products for nasal spray testing
CounterAct gets US patent for its naloxone nasal spray cap
The US Patent and Trademark Office has issued US Patent No. 10,933,204, titled "Prescription bottle cap capable of administering opioid overdose reversal agent" to CounterAct for its naloxone nasal spray cap, the company said. CounterAct is developing the nasal spray cap, which is designed to snap onto the top of a prescription pill bottle, for the reversal of opioid … [Read more...] about CounterAct gets US patent for its naloxone nasal spray cap